GTH Tagung 2010
54. Jahrestagung der Gesellschaft für Thrombose und Hämostaseforschung (GTH)
1. Joint Meeting GTH & NVTH Symposium of the Nederlandse Vereniging voor Trombose en Hemostase (NVTH)
February 24 - 27, 2010 NürnbergKongresspräsidenten:
Prof. Dr. Ulrich Walter (Würzburg)
Prof. Dr. Frits Rosendaal (Leiden)
Offizielle Kongresshomepage GTH-Tagung 2010
Vielen Dank!
Wir möchten allen Tagungsbesuchern sowie unseren Vortragenden für ihr Interesse und ihre Unterstützung danken.
KONGRESSFOTOS STEHEN ONLINE UNTER:
Pictures GTH-NVTH meeting 2010
Kongress-Statistik:
Teilnehmer: 1474 (!)
Abstracts: 506- divided in:
374 Posterpräsentationen
83 Vorträge
49 Eingeladene Sprecher
DOWNLOAD DES ABSTRACTBANDES 2010:
![[pdf]](/home/styles/ext_pdf.gif)
Download des gesamten Abstractbandes als .pdf (3,198.9 KB)
- so erschienen in
Hämostaseologie 01/2010, Schattauer-Verlag.Inhaltsverzeichnis Abstractband - siehe unten.
Präsentationen des BAYER Grant Workshops "Research funding for scientists from Austria, Germany, the Netherlands and Switzerland" vom 25. Februar 2010 - Experten wichtiger Forschungsförderungs-Organisationen präsentierten und diskutierten verschiedene Möglichkeiten und gaben Tipps
zur Einreichung um Grants im europäischen Raum:
GTH2010BayerGrantWorkshop_1a_Schneider_englisch_final.pdf (4,360.7 KB)
GTH2010BayerGrantWorkshop_1b_Schneider_deutsch_final.pdf (4,456.0 KB)
GTH2010BayerGrantWorkshop_2a_Staeck_Englisch_final.pdf (2,714.9 KB)
GTH2010BayerGrantWorkshop_2b_Staeck_Deutsch_final.pdf (2,719.4 KB)
GTH2010BayerGrantWorkshop_4a_Parsons_Englisch_final.pdf (787.0 KB)
GTH2010BayerGrantWorkshop_4b_Parsons_Deutsch_final.pdf (815.3 KB)
Interessierte für den Vortrag Specific Programme “Ideas” in FP7: The European Research Council (ERC) wenden sich bitte direkt an:
Nicole Schröder, LL.M.
EU-Büro des BMBF, PT-DLR
Nationale Kontaktstelle Recht und Finanzen im 7. FRP
Joseph-Schumpeter-Allee 1 (Besucheranschrift)
Heinrich-Konen-Str. 1 (Postanschrift)
53227 Bonn
Tel: 0049(0)228/3821-658
Fax: 0049(0)228/3821-649
E-Mail: nicole.schroeder@dlr.de
INHALTSVERZEICHNIS Abstractband 2010 (Download siehe oben):Plenary Lecture SessionsPL1
Current insight into diagnostics and pathophysiology of the antiphospholipid syndrome
Philip G. de Groot (Utrecht)
Heparin-induced thrombocytopenia
Andreas Greinacher (Greifswald)
PL2
Genetics and epidemiology of thrombophilia
Frits Rosendaal (Leiden)
Inflammation, innate immunity and blood coagulation
Charles T. Esmon (Oklahoma)
PL3
Coagulant response in sepsis and inflammation
Marcel Levi (Amsterdam)
Coagulation pathways in response to injury
Hartmut Weiler (Milwaukee)
PL4
Platelets, the coagulation system and placental development
Berend Isermann (Heidelberg)
Pregnancy and thrombophilia
Saskia Middeldorp (Leiden)
PL5
Update on platelet function disorders
Marco Cattaneo (Milano)
Arterial thrombus formation: Novel mechanisms and targets
Bernhard Nieswandt (Würzburg)
PL6
Platelet signaling defects and bleeding disorders
Steve Watson (Birmingham)
New insight into the molecular basis of hemophilia
Johannes Oldenburg (Bonn)
State of the Art Review ArticlesR1 Inflammation, innate immunity and blood coagulation
J. Xu; F. Lupu; C. T. Esmon
R2 The coagulant response in sepsis and inflammation
M. Levi
R3 Heparin-induced thrombocytopenia
A. Greinacher; K. Althaus; K. Krauel; S. Selleng
R4 Phenotypic approaches to gene mapping in platelet function disorders: Identification of new mutants of P2Y12, TXA2 and GPIV
S. Watson; M. Daly; B. Dawood; P. Gissen; M. Makris; S. Mundell; J. Wilde; A. Mumford
SymposiaSY01 Coagulation factor signaling....................................... A 3
SY02 Venous thrombosis I................................................... A 4
SY03 Risk stratification in acute pulmonary embolism
and deep vein thrombosis................................................... A 4
SY04 Inflammation and hemostasis..................................... A 5
SY05 Vascular biology/EPCs................................................. A 6
SY06 Contact activation........................................................ A 6
SY07 vWF and platelets....................................................... A 7
SY08 Antiplatelet therapy and monitoring............................ A 8
SY09 Platelets: Novel aspects.............................................. A 9
SY10 Fibrinolysis................................................................... A 10
SY11 Structure and function of coagulation factors.............. A 11
SY12 Anticoagulation........................................................... A 12
SY13 What’s new (and hot) in paediatric hemostasis.......... A 13
SY14 Hemostasis in the elderly ........................................... A 15
SY15 Microparticles.............................................................. A 16
SY16 Novel diagnostic approaches...................................... A 17
SY17 Megakaryocytes.......................................................... A 17
EPG (European Platelet Group)
EPG1 Platelet signaling......................................................... A 18
EPG2 Platelet functions......................................................... A 19
EPG3 Thrombosis models...................................................... A 20
Best Abstracts...................................................................... A 21
Free Communications
FC1 Platelet and platelet proteins: basic research................ A 22
FC2 Antiphospholipid syndrome, TTP: basic research............ A 24
FC3 Therapeutic aspects in hemostasis and transfusion medicine................................................................................ A 25
FC4 vWD and Hemophilia: clinical investigation..................... A 27
FC5 Arterial thrombosis, APS and HIT................................... A 28
FC6 Thrombosis: clinical investigation................................... A 29
FC7 Endothelial and vascular (dys-) function........................ A 31
FC8 Platelets: clinical aspects............................................... A 32
Posters
P01 Thrombotic disorders..................................................... A 33
P02 Venous thrombosis........................................................ A 39
P03 Arterial thrombosis, atherothrombotic diseases............ A 42
P04 Antiphospholipid syndrome, antibody
syndromes............................................................................ A 43
P05 Hemorrhagic disorders................................................... A 44
P06 Hemophilia, inherited coagulation disorders.................. A 57
P07 von Willebrand disease, vWF......................................... A 65
P08 Platelets, clinical aspects............................................... A 71
P09 Pathogenesis and treatment of HIT, ITP ...................... A 77
P10 Platelet function tests, clinical aspects.......................... A 81
P11 EPG: platelets, clinical.................................................... A 86
P12 Platelets, basic aspects.................................................. A 87
P13 Mechanisms of platelet activation / inhibition ................ A 92
P14 EPG: platelets, basics..................................................... A 95
P15 Coagulation – Fibrinolysis .............................................. A 96
P16 Anticoagulation............................................................... A 103
P17 Coagulation/Fibrinolysis: Laboratory methods,
biomarkers, experimental models.......................................... A 109
P18 Vascular Biology.............................................................. A 115
P19 Other Abstract Topics...................................................... A 122
Authors ................................................................................. A 125